Certified by Founder Lodge
Stage 2 Capital
United States - Greater New York City Area
INVESTOR
1 Disclosed Funding Rounds $5,000,000
27 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Stage 2 Capital is a venture capital firm that invests in early stage B2B software companies and sits shoulder to shoulder with leadership teams to operationalize sustainable revenue growth a
| Company | Date | Round | Raised |
|---|---|---|---|
 MVP Match |
September, 15 ,2022 | Seed | $5,000,000 |
 Veremark |
July, 20 ,2022 | Series A | $8,500,000 |
 AeroCloud |
February, 24 ,2023 | Series A | $12,600,000 |
 QuotaPath |
April, 26 ,2022 | Series B | $41,000,000 |
 Meaningful Gigs |
March, 18 ,2022 | Seed | $6,000,000 |
 PerchPeek |
February, 22 ,2022 | Series A | $11,000,000 |
 Occupier |
February, 15 ,2022 | Series A | $10,500,000 |
 DeepScribe |
January, 13 ,2022 | Series A | $30,000,000 |
 Gappify |
May, 02 ,2023 | Series B | $10,000,000 |
 Cable |
May, 12 ,2023 | Series A | $11,000,000 |
 Opus Training |
May, 25 ,2023 | Series A | $6,800,000 |
 Versori |
June, 29 ,2023 | Unknown | $3,500,000 |
 MedScout |
June, 30 ,2023 | Seed | $5,000,000 |
 Slang.ai |
July, 03 ,2023 | Unknown | $20,000,000 |
 Bevz |
September, 19 ,2023 | Unknown | $3,100,000 |
 Auquan |
October, 20 ,2023 | Unknown | $3,500,000 |
 Tofu |
October, 23 ,2023 | Seed | $5,000,000 |
 Stockpress |
November, 02 ,2023 | Seed | $1,800,000 |
 Metaplane |
March, 06 ,2024 | Series A | $13,800,000 |
 Rally UXR |
April, 10 ,2024 | Seed | $8,800,000 |
 Pear Commerce |
June, 28 ,2024 | Series A | $10,000,000 |
 nodaFi |
July, 09 ,2024 | Seed | $3,500,000 |
 Momentum.io |
July, 24 ,2024 | Series A | $13,000,000 |
 Gigpro |
July, 31 ,2024 | Series A | $16,000,000 |
 Champion |
September, 03 ,2024 | Seed | $3,300,000 |
 Persana AI |
November, 01 ,2024 | Unknown | $2,300,000 |
 Athenic AI |
January, 31 ,2025 | Unknown | $4,300,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
